Posted on August 12, 2008 by crimsoncanary
Addition of PI3K inhibitor LY-294002 to S.mutans stimulated human odontoblast-like cells resulted in the reduced gene expression of IL-6 and IL-8
Filed under: kinase | Tagged: kinase, LY-294002, LY294002, PI3K, Preclinical, Research | Comments Off
Posted on August 12, 2008 by crimsoncanary
Schering Plough have initiated a phase I trial of CDK 1/2/9 inhibitor SCH 727965 in patients with advanced breast and lung cancers
Filed under: kinase | Tagged: CDD1, CDK, CDK2, CDK9, kinase, SCH-727965, SCH727965, Schering, Schering Plough | Comments Off
Posted on August 12, 2008 by crimsoncanary
EntreMed have partnered with JSB-Partners to enhance business development and partnering activities for its lead Aurora A/angiogenesis kinase inhibitor, ENMD-2076.
Filed under: kinase | Tagged: aurora, ENMD-2076, ENMD2076, Entremed, kinase | Comments Off
Posted on August 12, 2008 by crimsoncanary
Cytopia have announced that it will be presenting data on its JAK2 program at the Philadelphia ACS meeting.
Filed under: kinase | Tagged: Cytopia, JAK2, kinase | Comments Off